Edwards Lifesciences (EW) Sector
Health Care

(Current) $87.02
1.66 (1.94%) Open Price: 85.22

 

Edwards Lifesciences Corporation is a global medical technology company that specializes in the design, development, and manufacture of medical devices for the treatment of cardiovascular disease. The company was founded in 1958 by Miles "Lowell" Edwards and Baxter Healthcare, and it is headquartered in Irvine, California. Edwards Lifesciences is one of the largest companies in the world focused solely on cardiovascular disease, with operations in more than 100 countries and a workforce of over 14,000 employees.

 

Edwards Lifesciences is best known for its heart valve products, including the SAPIEN 3 transcatheter aortic valve replacement (TAVR) system, which is used to treat patients with severe aortic stenosis who are considered too high-risk for traditional open-heart surgery. The company also manufactures other heart valve products, such as the Carpentier-Edwards PERIMOUNT Magna Ease aortic heart valve and the INSPIRIS RESILIA aortic valve, as well as hemodynamic monitoring systems, which measure blood flow and pressure in the heart and blood vessels.

 

In addition to its heart valve products, Edwards Lifesciences also offers a range of critical care products and services. These include hemodynamic monitoring systems for use in intensive care units (ICUs) and operating rooms, as well as disposable pressure sensors and catheters. The company's critical care products are used to monitor and manage patients with a variety of medical conditions, including sepsis, heart failure, and respiratory failure.

 

Edwards Lifesciences has a strong commitment to innovation and invests heavily in research and development to bring new products and technologies to market. The company has a number of ongoing research and development programs focused on improving patient outcomes and reducing the costs associated with treating cardiovascular disease. Additionally, Edwards Lifesciences has a robust clinical trial program that includes both company-sponsored and investigator-initiated trials.

 



 

(03/01/24) $85.22
(03/04/24) $85.36
(03/04/24) (Qty.)3,602,680
(03/01/24) $83.61
(03/01/24) $85.74
(10/29/23) $60.57
(06/25/23) $94.87
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing